174 related articles for article (PubMed ID: 22111461)
1. Increasing rate of detection of fusidic acid resistance in methicillin-resistant Staphylococcus aureus isolated from clinical samples in Malaysia.
Alreshidi MA; Mariana NS
Med J Malaysia; 2011 Aug; 66(3):276. PubMed ID: 22111461
[No Abstract] [Full Text] [Related]
2. Introduction: fusidic acid enters the United States.
Moellering RC; Corey GR; Grayson ML
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S467-8. PubMed ID: 21546622
[No Abstract] [Full Text] [Related]
3. Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus.
Wang JL; Tang HJ; Hsieh PH; Chiu FY; Chen YH; Chang MC; Huang CT; Liu CP; Lau YJ; Hwang KP; Ko WC; Wang CT; Liu CY; Liu CL; Hsueh PR
Int J Antimicrob Agents; 2012 Aug; 40(2):103-7. PubMed ID: 22612900
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
Yu XH; Song XJ; Cai Y; Liang BB; Lin DF; Wang R
J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368
[TBL] [Abstract][Full Text] [Related]
5. Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin.
Lemaire S; Van Bambeke F; Pierard D; Appelbaum PC; Tulkens PM
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S493-503. PubMed ID: 21546626
[TBL] [Abstract][Full Text] [Related]
6. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale.
Williamson DA; Monecke S; Heffernan H; Ritchie SR; Roberts SA; Upton A; Thomas MG; Fraser JD
Clin Infect Dis; 2014 Nov; 59(10):1451-4. PubMed ID: 25139961
[TBL] [Abstract][Full Text] [Related]
7. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
Howden BP; Grayson ML
Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
[TBL] [Abstract][Full Text] [Related]
8. In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States.
Jones RN; Mendes RE; Sader HS; Castanheira M
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S477-86. PubMed ID: 21546624
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
Apisarnthanarak A; Mundy LM
Int J Infect Dis; 2007 May; 11(3):283-4. PubMed ID: 16876452
[No Abstract] [Full Text] [Related]
10. Antibiotic resistance and molecular subtypes of clinical methicillin-resistant Staphylococcus aureus in a teaching hospital.
Zeinali E; Moniri R; Musavi GH
Indian J Med Microbiol; 2011; 29(3):318-9. PubMed ID: 21860123
[No Abstract] [Full Text] [Related]
11. [Frequency of methicilin-resistant Staphylococcus aureus strains in clinical spacimens obtained from hospitalized patients in 2007].
Mihajlović-Ukropina M; Medić D; Jelesić Z; Dautović R; Stefan-Mikić S; Sević S
Med Pregl; 2008; 61 Suppl 1():27-30. PubMed ID: 19256065
[TBL] [Abstract][Full Text] [Related]
12. Case report: treatment of chronic osteomyelitis.
Wolfe CR
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S538-41. PubMed ID: 21546631
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis.
Østergaard C; Yieng-Kow RV; Knudsen JD; Frimodt-Møller N; Espersen F
J Antimicrob Chemother; 2003 May; 51(5):1301-5. PubMed ID: 12697637
[TBL] [Abstract][Full Text] [Related]
14. Increasing resistance to fusidic acid among clinical isolates of MRSA.
Wang JT; Huang IW; Chang SC; Tan MC; Lai JF; Chen PY; Lauderdale TL
J Antimicrob Chemother; 2017 Feb; 72(2):616-618. PubMed ID: 27733516
[No Abstract] [Full Text] [Related]
15. Glycopeptides--important treatment option for methicillin-resistant Staphylococcus aureus.
Arora S; Arora U
Indian J Med Microbiol; 2011; 29(3):313-4. PubMed ID: 21860119
[No Abstract] [Full Text] [Related]
16. New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus.
Bouza E
Clin Microbiol Infect; 2009 Dec; 15 Suppl 7():44-52. PubMed ID: 19951334
[TBL] [Abstract][Full Text] [Related]
17. Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK.
Lewis T; Chaudhry R; Nightingale P; Lambert P; Das I
Int J Infect Dis; 2011 Feb; 15(2):e131-5. PubMed ID: 21134776
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous.
Liu Y; Kong F; Zhang X; Brown M; Ma L; Yang Y
Br J Dermatol; 2009 Dec; 161(6):1347-50. PubMed ID: 19754868
[TBL] [Abstract][Full Text] [Related]
19. [Persistent bacteremia due to methicillin-resistant Staphylococcus aureus. A result of inadequate treatment].
Parra-Ruiz J; Tomas-Jiménez C; Muñoz-Medina L; Hernández-Quero J
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):372-3. PubMed ID: 19339080
[No Abstract] [Full Text] [Related]
20. Trends in mupirocin resistance in meticillin-resistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital.
Lee AS; Macedo-Vinas M; François P; Renzi G; Vernaz N; Schrenzel J; Pittet D; Harbarth S
J Hosp Infect; 2011 Apr; 77(4):360-2. PubMed ID: 21276638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
